110 related articles for article (PubMed ID: 12810756)
1. Time course of vascular structural changes during and after short-term antihypertensive treatment.
Hale TM; Shoichet MJ; Bushfield TL; Adams MA
Hypertension; 2003 Aug; 42(2):171-6. PubMed ID: 12810756
[TBL] [Abstract][Full Text] [Related]
2. Short-term ACE inhibition confers long-term protection against target organ damage.
Hale TM; Robertson SJ; Burns KD; deBlois D
Hypertens Res; 2012 Jun; 35(6):604-10. PubMed ID: 22318205
[TBL] [Abstract][Full Text] [Related]
3. Effect of simvastatin given alone and in combination with valsartan or enalapril on blood pressure and the structure of mesenteric resistance arteries and the basilar artery in the genetically hypertensive rat model.
Ledingham JM; Laverty R
Clin Exp Pharmacol Physiol; 2005; 32(1-2):76-85. PubMed ID: 15730439
[TBL] [Abstract][Full Text] [Related]
4. Persistent lowering of arterial pressure after continuous and intermittent therapy.
Woolard J; Hale TM; Bushfield TL; Adams MA
J Hypertens; 2003 Apr; 21(4):813-20. PubMed ID: 12658029
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
Palmieri V; Devereux RB
Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
[TBL] [Abstract][Full Text] [Related]
6. Protection against L-NAME-induced reduction in cardiac output persists even after cessation of angiotensin-converting enzyme inhibitor treatment.
Biwer LA; Broderick TL; Xu H; Carroll C; Hale TM
Acta Physiol (Oxf); 2013 Jan; 207(1):156-65. PubMed ID: 22834875
[TBL] [Abstract][Full Text] [Related]
7. Reducing blood pressure in SHR with enalapril provokes redistribution of NHE3, NaPi2, and NCC and decreases NaPi2 and ACE abundance.
Yang LE; Leong PK; McDonough AA
Am J Physiol Renal Physiol; 2007 Oct; 293(4):F1197-208. PubMed ID: 17652375
[TBL] [Abstract][Full Text] [Related]
8. "Pulse" treatment with high-dose angiotensin blocker reverses renal arteriolar hypertrophy and regresses hypertension.
Ishiguro K; Hayashi K; Sasamura H; Sakamaki Y; Itoh H
Hypertension; 2009 Jan; 53(1):83-9. PubMed ID: 19047581
[TBL] [Abstract][Full Text] [Related]
9. Effects of angiotensin-converting enzyme inhibitory peptide LAP on vascular remodeling.
Huang J; Luo M; Fang H; Zheng H; Shen Y; Li L; Deng Y; Xu H
Clin Exp Hypertens; 2013; 35(6):437-43. PubMed ID: 23198680
[TBL] [Abstract][Full Text] [Related]
10. Age-related increase in sensitivity for ischemic ATP breakdown in hypertrophic hearts of SHR normalized by enalapril.
Schoemaker RG; Leenen FH; Harmsen E
J Mol Cell Cardiol; 1994 May; 26(5):649-60. PubMed ID: 8072019
[TBL] [Abstract][Full Text] [Related]
11. Combination of non-hypotensive doses of valsartan and enalapril improves survival of spontaneously hypertensive rats with endothelial dysfunction.
de Gasparo M; Hess P; Nuesslein-Hildesheim B; Bruneval P; Clozel JP
J Renin Angiotensin Aldosterone Syst; 2000 Jun; 1(2):151-8. PubMed ID: 11967807
[TBL] [Abstract][Full Text] [Related]
12. Effects of enalapril and hydralazine treatment and withdrawal upon cardiovascular hypertrophy in stroke-prone spontaneously hypertensive rats.
King RA; Smith RM; Krishnan R; Cleary EG
J Hypertens; 1992 Sep; 10(9):919-28. PubMed ID: 1328373
[TBL] [Abstract][Full Text] [Related]
13. Impact of antihypertensive treatments on erectile responses in aging spontaneously hypertensive rats.
Hannan JL; Smallegange C; Hale TM; Heaton JP; Adams MA
J Hypertens; 2006 Jan; 24(1):159-68. PubMed ID: 16331114
[TBL] [Abstract][Full Text] [Related]
14. Recovery of erectile function after brief aggressive antihypertensive therapy.
Hale TM; Okabe H; Bushfield TL; Heaton JP; Adams MA
J Urol; 2002 Jul; 168(1):348-54. PubMed ID: 12050568
[TBL] [Abstract][Full Text] [Related]
15. Changes critical to persistent lowering of arterial pressure in spontaneously hypertensive rat occur early in antihypertensive treatment.
Hale TM; Bushfield TL; Woolard J; Pang JJ; Rees-Milton KJ; Adams MA
J Hypertens; 2011 Jan; 29(1):113-22. PubMed ID: 20871411
[TBL] [Abstract][Full Text] [Related]
16. Effects of enalapril and eprosartan on the renal vascular nitric oxide system in human essential hypertension.
Delles C; Jacobi J; John S; Fleischmann I; Schmieder RE
Kidney Int; 2002 Apr; 61(4):1462-8. PubMed ID: 11918753
[TBL] [Abstract][Full Text] [Related]
17. Long-term effects of treatment with enalapril on the structure of mesenteric resistance arteries in New Zealand genetically hypertensive rats.
Ledingham JM; Laverty R
Clin Exp Pharmacol Physiol Suppl; 1995 Dec; 22(1):S350-2. PubMed ID: 9072424
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular structural changes and calcium antagonist therapy in patients with hypertension.
Agabiti-Rosei E; Muiesan ML; Rizzoni D; Zulli R; Calebich S; Castellano M; Cavaliere G; Nordio G; Pasini F; Zuccato F
J Cardiovasc Pharmacol; 1994; 24 Suppl A():S37-43. PubMed ID: 7603076
[TBL] [Abstract][Full Text] [Related]
19. Control of vascular changes by renin-angiotensin-aldosterone system in salt-sensitive hypertension.
Zeng ZH; Luo BH; Gao YJ; Su CJ; He CC; Yi JJ; Li N; Lee RM
Eur J Pharmacol; 2004 Oct; 503(1-3):129-33. PubMed ID: 15496307
[TBL] [Abstract][Full Text] [Related]
20. Reduction in left ventricular hypertrophy in hypertensive patients treated with enalapril, losartan or the combination of enalapril and losartan.
Avanza AC; El Aouar LM; Mill JG
Arq Bras Cardiol; 2000 Feb; 74(2):103-17. PubMed ID: 10904284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
